205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.65%
Revenue growth below 50% of MCHP's 10.82%. Michael Burry would check for competitive disadvantage risks.
1.61%
Cost growth less than half of MCHP's 6.26%. David Dodd would verify if cost advantage is structural.
12.33%
Similar gross profit growth to MCHP's 15.09%. Walter Schloss would investigate industry dynamics.
8.38%
Margin expansion exceeding 1.5x MCHP's 3.85%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.10%
Operating expenses growth while MCHP reduces costs. John Neff would investigate differences.
2.28%
Total costs growth while MCHP reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
86.67%
D&A growth while MCHP reduces D&A. John Neff would investigate differences.
146.88%
Similar EBITDA growth to MCHP's 144.00%. Walter Schloss would investigate industry trends.
145.23%
EBITDA margin growth 1.25-1.5x MCHP's 120.17%. Bruce Berkowitz would examine sustainability.
1050.00%
Operating income growth exceeding 1.5x MCHP's 132.00%. David Dodd would verify competitive advantages.
1016.58%
Operating margin growth exceeding 1.5x MCHP's 128.88%. David Dodd would verify competitive advantages.
-104.35%
Other expenses reduction while MCHP shows 29.56% growth. Joel Greenblatt would examine advantage.
-14.29%
Pre-tax income decline while MCHP shows 90.61% growth. Joel Greenblatt would examine position.
-17.30%
Pre-tax margin decline while MCHP shows 91.53% growth. Joel Greenblatt would examine position.
-12.50%
Tax expense reduction while MCHP shows 120.44% growth. Joel Greenblatt would examine advantage.
-15.38%
Net income decline while MCHP shows 87.97% growth. Joel Greenblatt would examine position.
-18.36%
Net margin decline while MCHP shows 89.14% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.01%
Share count reduction exceeding 1.5x MCHP's 0.33%. David Dodd would verify capital allocation.
0.01%
Diluted share reduction exceeding 1.5x MCHP's 0.33%. David Dodd would verify capital allocation.